E3

More spice did not improve post-meal metabolism. A four-week trial complicates the heart-health story

Lymphoma Is Testing How Far Chemo-Free Care Can Go

Bayer’s ESC 2026 programme puts the heart-kidney axis centre stage. Disease silos are starting to look obsolete

Gut bacteria could help explain how vegetable-rich diets protect cardiometabolic health

Cancer Survivorship Standards Are Still Mostly Paper

MS Prevention Is Still Too Passive

Four in five young adults in an urban U.S. cohort had CKM risk factors. Cardiovascular prevention is arriving too late

Coffee drinkers had less visceral fat despite similar BMI. The finding exposes what the scale misses

Breast Cancer Immunotherapy Has a New Problem: Who Gets the Second Checkpoint?
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
